Global Oncology Academy
The Global Oncology Academy (GOA) is an educational platform for physicians and other healthcare professionals involved in oncology. Its mission is to increase knowledge regarding the disease course of specific cancers and address key elements for successful management. The GOA series will also share the science around innovations in combination therapies, oncology strategies, and new developments.
For more information about GOA, visit www.globaloncologyacademy.org.
166-180 of 474
The Clinical Consequences of Delayed Colorectal Cancer Screening
Clinician's RoundtableThe Clinical Consequences of Delayed Colorectal Cancer Screening
Peter Buch, MD, FACG, AGAF, FACP
Christopher Cann, MD
Preventing Colorectal Cancer with Smart Screening
Clinician's RoundtablePreventing Colorectal Cancer with Smart Screening
Harish Gagneja, MD
Using FTIR to Support Accurate Tissue Assessment in Colorectal Surgery
Clinician's RoundtableUsing FTIR to Support Accurate Tissue Assessment in Colorectal Surgery
Ashley Baker, MSN, PMHNP
Heather Allen, PhD
Ran Li, PhD
Cost Considerations for Colorectal Cancer Screening: Examining the Data
Clinician's RoundtableCost Considerations for Colorectal Cancer Screening: Examining the Data
Supplement Use for Colorectal Cancer Prevention: Insights from NCCN Guidelines
Clinician's RoundtableSupplement Use for Colorectal Cancer Prevention: Insights from NCCN Guidelines
Reid Ness, MD
How Colorectal Cancer Screening Fits into OB/GYN Care
Clinician's RoundtableHow Colorectal Cancer Screening Fits into OB/GYN Care
Mallik Greene, PhD
- advertisement
Improving CRC Screening Uptake: An Integrated Approach
Clinician's RoundtableImproving CRC Screening Uptake: An Integrated Approach
Mallik Greene, PhD
Initiating Colorectal Cancer Screening Earlier: A Look at the Evidence
Clinician's RoundtableInitiating Colorectal Cancer Screening Earlier: A Look at the Evidence
Theodore Levin, MD
Optimizing Colorectal Cancer Screening: A Stress Test of Current Guidelines
Clinician's RoundtableOptimizing Colorectal Cancer Screening: A Stress Test of Current Guidelines
Pedro Nascimento de Lima, PhD
Streamlining Colorectal Cancer Screening in OB/GYN Care
Clinician's RoundtableStreamlining Colorectal Cancer Screening in OB/GYN Care
Jemel Bingham, MD
Addressing Barriers to Colorectal Cancer Screening in Rural Populations
Clinician's RoundtableAddressing Barriers to Colorectal Cancer Screening in Rural Populations
Peter Buch, MD, FACG, AGAF, FACP
Michael Dougherty, MD
ctDNA-Guided Adjuvant Atezolizumab in MIBC: IMvigor011 Insights
Project Oncology®ctDNA-Guided Adjuvant Atezolizumab in MIBC: IMvigor011 Insights
Charles Turck, PharmD, BCPS, BCCCP
Guru P. Sonpavde, MD
- advertisement
Boosting Colorectal Cancer Re-Screening: The Role of Spanish Language Navigation
Clinician's RoundtableBoosting Colorectal Cancer Re-Screening: The Role of Spanish Language Navigation
Ryan Quigley
Mallik Greene, PhD
Colorectal Cancer Screening: Evaluating the Cost-Effectiveness of Noninvasive Options
Clinician's RoundtableColorectal Cancer Screening: Evaluating the Cost-Effectiveness of Noninvasive Options
Brian P. McDonough, MD, FAAFP
Carolyn Rutter, PhD
Gloria Coronado, PhD
Adherence to OB/GYN-Ordered CRC Screening: Real-World Insights
Clinician's RoundtableAdherence to OB/GYN-Ordered CRC Screening: Real-World Insights
Mallik Greene, PhD